Challenge 03
Find risk earlier. Connect people to care sooner.
Emerging technologies are creating new opportunities to identify potential healthcare risk earlier and connect people with appropriate evaluation, existing programs, care, and continued support.
01 — The problem
Too much risk is found too late.
Cardiometabolic disease and related conditions can progress quietly. By the time risk becomes visible through claims, an acute event, or a clinical encounter, the condition may already be more complex and costly to address.
Traditional screening can also create significant friction: appointments, transportation, laboratory visits, preparation requirements, and time away from work. Many of the people who could benefit most never participate.
- 01
Find
- 02
Intervene
- 03
Connect
- 04
Continue
Earlier identification creates value only when it leads to an appropriate intervention, a successful connection to care, and continued engagement.
02 — What has changed
Low-friction screening can change when problems are found.
New screening capabilities can reach people who do not participate in traditional screening and surface potential health risks earlier. That creates more time to connect individuals with appropriate evaluation, existing programs, care, and ongoing support.
The opportunity is not simply to introduce another screening technology. It is to make earlier identification part of a connected operating model that moves from a risk signal to an appropriate next step.
Strategic implementation partner
Bringing earlier risk identification into healthcare workflows
Hibiscus Health’s Healthy Selfie™ uses a patented, clinically validated, 30-second facial scan to flag potential cardiometabolic risk for follow-up. It is a screening capability, not a diagnostic tool.
Embel Assist serves as Hibiscus Health’s strategic integration partner, helping payer and provider organizations incorporate the capability into existing clinical, care-management, population-health, quality, and engagement workflows.
Together, we help ensure that an elevated-risk result leads to an appropriate next step—clinical evaluation, connection to an existing program, an in-home assessment, care-management support, or continued engagement.
Hibiscus Health
Provides the screening technology and risk insights.
Embel Assist
Integrates the capability into payer and provider workflows.
Healthcare organization
Establishes the populations, clinical policies, programs, and care pathways.
03 — The sequence
Earlier identification matters only when the full sequence works.
Screening is the beginning, not the outcome. Meaningful value depends on moving from risk identification to an appropriate intervention, a successful connection to care, and continued engagement over time.
FindIdentify risk earlier
Reach people who may be at risk before a condition becomes visible through claims, an acute event, or a scheduled clinical encounter.
FindIdentify risk earlier
Reach people who may be at risk before a condition becomes visible through claims, an acute event, or a scheduled clinical encounter.
From risk identification to a continuous healthcare relationship
Hibiscus Health can help surface potential risk. HealthVia℠ can help structure the adaptive journeys, communication preferences, next-best actions, and continued engagement that follow. Embel Assist brings these capabilities into the client’s existing programs and operating environment.
Where this can make a meaningful difference
Earlier risk identification can extend preventive care beyond the people who already participate in traditional screening.
Employer population health
Reach employees who do not participate in onsite screenings or routine preventive care and connect those with elevated risk to available benefits, clinical evaluation, and support programs.
Health plan prevention programs
Identify members who may benefit from additional evaluation and connect them with care management, prevention, quality, and existing condition-management programs.
Health system population health
Extend risk identification beyond scheduled visits and create pathways that bring appropriate individuals into primary care, preventive services, or clinical follow-up.
Existing wellness and chronic-condition programs
Identify people who may benefit from programs already available and guide them from screening through enrollment, participation, and continued engagement.
Home-based care and house-call programs
Extend risk identification into the home, help prioritize individuals who may benefit from an in-home assessment, and connect screening results with house-call visits, primary care, care management, and continued support.
Pharmacy and medication programs
Identify individuals who may benefit from clinical evaluation, medication-related support, or referral into existing pharmacy and condition-management programs.
04 — The work
What successful preventive implementation requires
A screening capability creates value when it becomes part of the organization’s existing clinical, quality, care-management, population-health, and engagement operations. That requires clearly defined populations, workflows, destinations, integrations, and measurement.
Select the population
Define who the capability is intended to reach, why they may benefit, who is currently being missed, and how the program will reach them.
Select the population
Define who the capability is intended to reach, why they may benefit, who is currently being missed, and how the program will reach them.
05 — What Embel Assist does
We make earlier risk identification operational.
As Hibiscus Health’s strategic integration partner, Embel Assist helps payer and provider organizations incorporate screening into the clinical, operational, technology, and engagement workflows that determine what happens next.
Population and use-case strategy
Identify the populations, risk-identification opportunities, existing programs, desired outcomes, and implementation priorities that create a meaningful starting point.
Payer and provider workflow integration
Design how screening results enter care management, population health, quality, scheduling, referral, home-based care, and clinical follow-up workflows.
Member and patient experience design
Create a clear, low-friction experience around screening, results, next steps, human support, and continued engagement.
Solution architecture and system integration
Connect the capability with engagement platforms, care-management systems, scheduling, clinical workflows, reporting, and systems of record.
Implementation and change management
Coordinate configuration, integration, testing, stakeholder alignment, deployment, training, and organizational adoption.
Operational readiness and optimization
Establish ownership, measurement, support processes, governance, and continuous improvement so the capability produces value beyond the initial launch.
Across the lifecycle
Strategy
Define the population, use case, existing program, desired outcomes, clinical destination, business value, and implementation roadmap.
Strategy
Define the population, use case, existing program, desired outcomes, clinical destination, business value, and implementation roadmap.
06 — Responsible implementation
Principles for responsible prevention
Earlier risk identification creates an obligation to communicate clearly, provide an appropriate destination for results, support equitable access, and measure outcomes responsibly. These principles guide how we evaluate and implement preventive capabilities.
Clear boundary
Screening and diagnosis remain distinct
Screening identifies people who may warrant additional evaluation. Clinical assessment, confirmatory testing, and diagnosis remain the responsibility of qualified healthcare professionals.
Defined pathway
Every result has a destination
Before launch, elevated-risk results must have an agreed destination, responsible owner, expected response, and appropriate communication path.
Inclusive by design
Access and equity are designed in
Screening and follow-up should account for device access, connectivity, language, accessibility, health literacy, and the needs of people who require alternative support.
Validated
Partner claims remain substantiated
Technology, validation, architecture, performance, privacy, and regulatory descriptions must use current, approved, evidence-supported partner language.
Evidence based
Outcomes are measured responsibly
Participation, connection, operational impact, cost, and clinical outcomes should be evaluated against an agreed baseline and measurement plan.
07 — Why it matters
Earlier is not a slogan. It is a different operating model.
When potential risk is identified earlier and connected to an appropriate response, organizations have more time to engage people, use the programs already in place, facilitate clinical follow-up, and provide continued support before conditions become more complex.
- Earlier risk visibility
- Greater screening access
- Faster connection to care
- Better use of existing programs
- Continued engagement
Start a conversation
Let’s get to work.
Tell us where earlier risk identification could strengthen an existing payer or provider program. We’ll help determine how the capability should connect to clinical workflows, engagement, and continued support.